Howard M. Gross

Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma

Thomas E. Witzig, Susan M. Geyer, Irene M. Ghobrial et al. · Journal of Clinical Oncology · 2005 · 520 citations

Seven-Year Follow-Up Assessment of Cardiac Function in NSABP B-31, a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel (ACP) With ACP Plus Trastuzumab As Adjuvant Therapy for Patients With Node-Positive, Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

Edward H. Romond, Jong‐Hyeon Jeong, Priya Rastogi et al. · Journal of Clinical Oncology · 2012 · 514 citations · Full text

Bevacizumab Added to Neoadjuvant Chemotherapy for Breast Cancer

Harry D. Bear, Gong Tang, Priya Rastogi et al. · New England Journal of Medicine · 2012 · 464 citations · Full text

Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study

Bret B. Friday, S. K. Anderson, J. Buckner et al. · Neuro-Oncology · 2011 · 210 citations · Full text

Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial

Richard G. Margolese, Reena S. Cecchini, Thomas B. Julian et al. · The Lancet · 2015 · 194 citations · Full text

Surgical Oncology, Breast Oncology, Medicine +10